Airway Clearance Devices Market Size By Device Type (Oscillatory Positive Expiratory Pressure (OPEP), High Frequency Chest Wall Oscillation (HFCWO)), By Application (Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis), By End-use, & Forecast, 20

Airway Clearance Devices Market Size By Device Type (Oscillatory Positive Expiratory Pressure (OPEP), High Frequency Chest Wall Oscillation (HFCWO)), By Application (Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis), By End-use, & Forecast, 2023 - 2032

Airway Clearance Devices Market size is anticipated to expand at 5.2% CAGR from 2023-2032, driven by the increasing adoption of portable and user-friendly devices for home-based respiratory care. Of late, the surging burden of chronic respiratory conditions is fueling the rising preference for convenient and comfortable treatment options. Moreover, the higher technological advancements leading to compact and easy-to-use devices along with supportive healthcare policies for encouraging home-based care will further propel the market expansion.

Rising investments in novel mechanisms, such as high-frequency chest wall oscillation and intrapulmonary percussive ventilation coupled with the increasing collaborations between industry players and research institutions are also fostering the development of next-generation airway clearance devices. To cite an instance, in July 2023, medical technology firm Inogen Inc. acquired Physio-Assist SAS, a privately held company headquartered in France to diversify its portfolio and expand its product offerings across the U.S. and EMEA to serve the chronic disease patients.

The airway clearance devices market is segmented into device type, application, end-use, and region.

With respect to device type, the industry value from the oscillatory positive expiratory pressure (OPEP) segment is estimated to gain significant traction from 2023-2032 owing to its efficacy in treating various respiratory conditions. The rising prevalence of chronic obstructive pulmonary disease (COPD) and cystic fibrosis is driving the demand for non-invasive and effective airway clearance solutions. Moreover, the surging preference for advanced OPEP device designs and increased healthcare expenditure on respiratory care will contribute to the segment growth.

Airway clearance devices market is likely to witness significant growth from the chronic obstructive pulmonary disease application segment between 2023 and 2032. The growing aging population, rapid rate of environmental pollution, and burden of smoking habits are leading to the increasing number of patients suffering from COPD. Additionally, the surging advancements in portable and user-friendly devices tailored to the needs of COPD patients will propel the segment expansion.

Regionally, the APAC airway clearance devices industry is set to expand at notable CAGR from 2023-2032 fueled by the rising prevalence of respiratory disorders, increasing awareness regarding pulmonary health, and the growing elderly population. The technological advancements, healthcare infrastructure developments, and government initiatives for supporting respiratory care are contributing to the market development. Additionally, the increasing collaborations between regional and international players along with the higher emphasis on R&D activities will bolster the regional industry growth.